United States· US:43598-132_45c22bbf-6332-4f7f-b77e-8ac613435821
HYDROXYCHLOROQUINE SULFATE
A hydroxychloroquine product containing hydroxychloroquine sulfate, registered in United States by Dr. Reddy's Laboratories Inc.. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Hydroxychloroquine is registered in 17 of 19 countries.
Countries holding a registration under ATC P01BA02 (hydroxychloroquine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Hydroxychloroquine · ATC P01BA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydroxychloroquine costs, country by country.
Normalised to the WHO defined daily dose (0.516 g), the median price runs from $0.33 in France to $1.28 in Switzerland — a ×3.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Hydroxychloroquine · price per daily dose (0.516 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.28
- IT Italy$0.45
- FR France$0.33
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYDROXYCHLOROQUINE SULFATE
- Manufacturer
- Dr. Reddy's Laboratories Inc.
- Country
- United States (US)
- ATC code
- P01BA02
- ATC class
- Hydroxychloroquine
- Defined daily dose
- 0.516 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc114359813201100 TABLET, FILM COATED in 1 BOTTLE (43598-132-01)
- ndc114359813205500 TABLET, FILM COATED in 1 BOTTLE (43598-132-05)
- ndc1143598-132-01
- ndc1143598-132-05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
748 interactions on record for hydroxychloroquine.
Graded by severity as the source publishes them — 220 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxychloroquine · interactions on record
748 records
- 220 severe
- 278 moderate
- 6 minor
- 244 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydroxychloroquine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandOxiklorinOrion Corporation
- United KingdomHydroxychloroquine 100mg/5ml oral solutionSpecial Order
- SpainDOLQUINE 200 mg COMPRIMIDOS RECUBIERTOSProducts And Technology S.L.
- CanadaAPO-HYDROXYQUINEAPOTEX INC
- GermanyHydroxychloroquin AristoAristo Pharma Gmbh (Art 57)
- NetherlandsHydroxychloroquinesulfaat 200 mg Focus, filmomhulde tablettenFocus Care Pharmaceuticals B.V.
- PolandAutokilaTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- NorwayHydroxychloroquinAristo Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Hyplaxy
- Belgium · Plaquenil
- Bulgaria · Моривид
- Cyprus · Plaquenil
- Czechia · Plaquenil
- Germany · Hydroxychloroquin Heumann, Hydroxychloroquin Ipca
- Denmark · Pimaxiro, Plaquenil
- Estonia · Hydroxychloroquine Auxilia, Plaquenil
- Spain · Dolquine, Duplaxil
- Finland · Oxiklorin
- France · Plaquenil
- United Kingdom (Northern Ireland) · Hydroxychloroquine Sulfate Accord-Uk, Hydroxychloroquine Sulfate Blackrock Pharmaceuticals
- Greece · Plaquenil
- Croatia · Hyplaxy
- Hungary · Hidroxiklorokin Meditop, Plaquenil
- Ireland · Plaquenil
- Iceland · Plaquenil
- Italy · Idrossiclorochina Aurobindo, Idrossiclorochina Doc
- Lithuania · Plaquenil
- Luxembourg · Plaquenil
- Latvia · Plaquenil
- Malta · Hydroxychloroquine Sulfate Ipca Laboratories Uk, Hydroxychloroquine Sulfate Ipca Produtos Farmaceuticos Unipessoal Lda
- Netherlands · Hydroxychloroquine Sulfate Aurobindo, Hydroxychloroquinesulfaat Cf
- Norway · Pimaxiro, Plaquenil
- Poland · Autokila, Hydroquenin
- Portugal · Hidroxicloroquina Basi, Hidroxicloroquina Generis
- Romania · Hidroxiclorochina Atb, Plaquenil
- Sweden · Pimaxiro, Plaquenil
- Slovenia · Hyplaxy
- Slovakia · Plaquenil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f3111bdd-a4ca-4008-8964-75eecb630ead GET /v1/drugs/f3111bdd-a4ca-4008-8964-75eecb630ead?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "300",
"substance": "HYDROXYCHLOROQUINE SULFATE",
"productndc": "43598-132",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA210441",
"marketing_category": "ANDA"
}See everything about hydroxychloroquine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.